The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities
Abstract
Purpose To determine whether gadolinium deposits in neural tissues of patients with intracranial abnormalities following intravenous gadolinium-based contrast agent (GBCA) exposure might be related to blood-brain barrier integrity by studying adult patients with normal brain pathologic characteristics. Materials and Methods After obtaining antemortem consent and institutional review board approval, the authors compared postmortem neuronal tissue samples from five patients who had undergone four to 18 gadolinium-enhanced magnetic resonance (MR) examinations between 2005 and 2014 (contrast group) with samples from 10 gadolinium-naive patients who had undergone at least one MR examination during their lifetime (control group). All patients in the contrast group had received gadodiamide. Neuronal tissues from the dentate nuclei, pons, globus pallidus, and thalamus were harvested and analyzed with inductively coupled plasma mass spectrometry (ICP-MS), transmission electron microscopy with energy-dispersive x-ray spectroscopy, and light microscopy to quantify, localize, and assess the effects of gadolinium deposition. Results Tissues from the four neuroanatomic regions of gadodiamide-exposed patients contained 0.1–19.4 μg of gadolinium per gram of tissue in a statistically significant dose-dependent relationship (globus pallidus: ρ = 0.90, P = .04). In contradistinction, patients in the control group had undetectable levels of gadolinium with ICP-MS. All patients had normal brain pathologic characteristics at autopsy. Three patients in the contrast group had borderline renal function (estimated glomerular filtration rate <45 mL/min/1.73 m2) and hepatobiliary dysfunction at MR examination. Gadolinium deposition in the contrast group was localized to the capillary endothelium and neuronal interstitium and, in two cases, within the nucleus of the cell. Conclusion Gadolinium deposition in neural tissues after GBCA administration occurs in the absence of intracranial abnormalities that might affect the permeability of the blood-brain barrier. These findings challenge current understanding of the biodistribution of these contrast agents and their safety. © RSNA, 2017
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Self-citationKanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., & Takenaka, D. (2014) · Radiology · doi:10.1148/radiol.13131669 · Cited by 1,339
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Rogosnitzky, M., & Branch, S. (2016) · BioMetals · doi:10.1007/s10534-016-9931-7 · Cited by 766
Radbruch, A., Weberling, L. D., Kieslich, P. J., Eidel, O., Burth, S., Kickingereder, P., Heiland, S., Wick, W., Schlemmer, H.-P., & Bendszus, M. (2015) · Radiology · doi:10.1148/radiol.2015150337 · Cited by 561
Toxicological Evaluations of Rare Earths and Their Health Impacts to Workers: A Literature Review
Rim, K. T., Koo, K. H., & Park, J. S. (2013) · Safety and Health at Work · doi:10.5491/shaw.2013.4.1.12 · Cited by 484
Kanda, T., Osawa, M., Oba, H., Toyoda, K., Kotoku, J., Haruyama, T., Takeshita, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.14140364 · Cited by 472
Errante, Y., Cirimele, V., Mallio, C. A., Di Lazzaro, V., Zobel, B. B., & Quattrocchi, C. C. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000072 · Cited by 421
Murata, N., Gonzalez-Cuyar, L. F., Murata, K., Fligner, C., Dills, R., Hippe, D., & Maravilla, K. R. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000252 · Cited by 408
Cited by
Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI
Gong, E., Pauly, J. M., Wintermark, M., & Zaharchuk, G. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25970 · Cited by 351
Cryptic footprints of rare earth elements on natural resources and living organisms
Adeel, M., Lee, J. Y., Zain, M., Rizwan, M., Nawab, A., Ahmad, M. A., Shafiq, M., Yi, H., Jilani, G., Javed, R., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.03.022 · Cited by 282
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
Do, C., DeAguero, J., Brearley, A., Trejo, X., Howard, T., Escobar, G. P., & Wagner, B. (2020) · Kidney360 · doi:10.34067/kid.0000272019 · Cited by 125
Metadata
- Authors
- McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Paolini, M. A., Murray, D. L., Williamson, E. E., & Eckel, L. J.
- Venue
- Radiology
- Published
- 2017-11
- Volume
- 285
- Issue
- 2
- Pages
- 546-554
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2695045525
- Cited by
- 318
- References
- 18
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities. https://app.cochat.ai/papers/10.1148/radiol.2017161595
- The paper
- McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Paolini, M. A., Murray, D. L., Williamson, E. E., & Eckel, L. J. (2017). Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities. Radiology. https://doi.org/10.1148/radiol.2017161595
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.